Evogene Ltd Ord (EVGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -17,213 | -14,530 | -8,878 | -2,520 | 640 |
| Depreciation Amortization | 2,433 | 2,249 | 2,042 | 1,830 | 1,410 |
| Accounts receivable | -1,785 | 788 | -426 | N/A | N/A |
| Accounts payable and accrued liabilities | -2,050 | -1,723 | -1,951 | N/A | N/A |
| Other Working Capital | -3,836 | -928 | -2,362 | -2,530 | 690 |
| Other Operating Activity | 10,044 | 5,249 | 6,305 | 1,340 | -610 |
| Operating Cash Flow | $-12,407 | $-8,895 | $-5,270 | $-1,880 | $2,130 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 18,439 | -79,466 | -1,287 | N/A | N/A |
| PPE Investments | -2,005 | -3,564 | -1,613 | -2,920 | -3,750 |
| Other Investing Activity | 953 | -1,000 | 0 | 21,400 | -26,830 |
| Investing Cash Flow | $17,387 | $-84,030 | $-2,900 | $18,480 | $-30,580 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 296 | 2,857 | 79,573 | N/A | N/A |
| Other Financing Activity | -251 | -191 | -165 | 1,110 | 25,570 |
| Financing Cash Flow | $45 | $2,666 | $79,408 | $1,110 | $25,570 |
| Exchange Rate Effect | -17 | 18 | -46 | 80 | -780 |
| Beginning Cash Position | 5,213 | 95,454 | 24,262 | 6,460 | 10,120 |
| End Cash Position | 10,221 | 5,213 | 95,454 | 24,260 | 6,460 |
| Net Cash Flow | $5,008 | $-90,241 | $71,192 | $17,790 | $-3,650 |
| Free Cash Flow | |||||
| Operating Cash Flow | -12,407 | -8,895 | -5,270 | -1,880 | 2,130 |
| Capital Expenditure | -2,005 | -3,564 | -1,613 | N/A | N/A |
| Free Cash Flow | -14,412 | -12,459 | -6,883 | -1,880 | 2,130 |